gnai1 Protein

📖 Wiki Page

protein995 wordssynced 2026-04-02

GNAI1 Protein (Gαi1)

Introduction

Gnai1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">G Protein Subunit Alpha i1</th></tr>
<tr><td>Gene Symbol</td><td>[GNAI1](/genes/gnai1)</td></tr>
<tr><td>UniProt ID</td><td>[P08708](https://www.uniprot.org/uniprot/P08708)</td></tr>
<tr><td>PDB ID</td><td>1BOF, 2GJA, 3MRK</td></tr>
<tr><td>Molecular Weight</td><td>40.4 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Plasma membrane, cytoplasm</td></tr>
<tr><td>Protein Family</td><td>Gαi/o family of heterotrimeric G proteins</td></tr>
<tr><td>Expression</td><td>Brain (cortex, hippocampus, basal ganglia, cerebellum), heart, pancreas</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/schizophrenia" style="color:#ef9a9a">Schizophrenia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">34 edges</a></td>
</tr>
</table>
</div>

Overview

...

GNAI1 Protein (Gαi1)

Introduction

Gnai1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

GNAI1 encodes the Gαi1 subunit, a member of the Gi/o family of heterotrimeric G proteins that inhibit adenylyl cyclase and regulate various downstream effectors.[^1] Gαi1 is widely expressed in the nervous system and plays critical roles in modulating neuronal signaling, synaptic transmission, and cellular responses to neurotransmitters. As an inhibitory G protein, GNAI1 couples to GPCRs to suppress cAMP production and activate downstream signaling pathways that influence neuronal excitability, metabolism, and gene expression.

Structure

Domain Architecture

Gαi1 contains the canonical G alpha subunit structure:

N-terminal helix: Myristoylation site for membrane anchoring
Switch I region: Conformational changes between active/inactive states (residues 42-52)
Switch II region: Critical for GTP hydrolysis (residues 62-71)
Switch III region: Effector interaction interface (residues 87-97)
GTPase domain: Catalytic core for GTP hydrolysis (residues 35-190)

Post-Translational Modifications

N-terminal glycine myristoylation: Required for membrane localization
Cys palmitoylation: Additional membrane anchoring
Phosphorylation: Serine/threonine phosphorylation regulates activity

Conformational States

Gαi1 cycles between two major conformations:

Active state: Bound to GTP, able to interact with effectors
Inactive state: Bound to GDP, complexed with Gβγ dimer

The intrinsic GTPase activity hydrolyzes GTP to GDP, providing a built-in timer for signal duration.[^2]

Normal Function

Gαi1 Signaling Cascade

Receptor activation: GPCRs (e.g., dopamine D2, serotonin 5-HT1, adenosine A1) couple to Gi proteins

GDP/GTP exchange: GDP releases and GTP binds to Gαi1

Gαi1-GTP formation: Active Gαi1 dissociates from Gβγ dimer

Effector modulation: Gαi1-GTP inhibits adenylyl cyclase, activates GIRK channels

Signal termination: GTP hydrolysis returns Gαi1 to inactive state

Key Effector Pathways

Adenylyl cyclase inhibition: Reduces cAMP production
GIRK channel activation: Hyperpolarizes [neurons](/entities/neurons) via K+ efflux
PI3K/Akt modulation: Influences cell survival pathways
ERK/MAPK regulation: Controls gene expression

Neuronal Functions

Synaptic transmission: Modulates neurotransmitter release
Neuronal excitability: Regulates resting membrane potential
Ion channel modulation: Controls calcium and potassium channels
Gene expression: Influences transcription via cAMP response

Expression Pattern

Brain Regional Distribution

GNAI1 is expressed throughout the brain:

Cerebral [cortex](/brain-regions/cortex): Pyramidal neurons and interneurons
[Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal cells, dentate gyrus granule cells
Basal ganglia: Striatal medium spiny neurons, substantia nigra
Cerebellum: Purkinje cells, granule cells
Thalamus: Relay neurons
Brainstem: Various nuclei

Cellular Localization

Plasma membrane: Primary location for GPCR coupling
Cytoplasm: cytosolic signaling pools
Synaptic vesicles: Associated with presynaptic terminals
Golgi apparatus: Post-translational processing

Role in Neurodegeneration

Alzheimer's Disease

GNAI1 dysfunction contributes to AD pathogenesis:[^3]

cAMP dysregulation: Altered Gαi1 signaling affects memory-related cAMP pathways
Amyloid-β effects: [Aβ](/proteins/amyloid-beta) modulates Gαi1-coupled receptor signaling
[Tau](/proteins/tau) pathology: Gαi1 dysfunction may interact with [tau](/proteins/tau) phosphorylation cascades
Synaptic plasticity: Impaired Gαi1 signaling affects [LTP](/mechanisms/long-term-potentiation)/LTD

Parkinson's Disease

D2 receptor signaling: GNAI1 couples D2 dopamine receptors, altered in PD
Basal ganglia dysfunction: Gαi1-mediated inhibition affects motor control
L-DOPA-induced dyskinesias: Altered Gαi1 signaling contributes
Neuroprotection: Gαi1 activation may protect dopaminergic neurons

Psychiatric Disorders

Schizophrenia: GNAI1 variants affect dopamine and serotonin signaling
Depression: Gαi1-coupled receptor dysfunction
Anxiety: GABA-B receptor signaling through Gαi1

Epilepsy

Neuronal excitability: Gαi1 mutations cause network hyperexcitability
Seizure susceptibility: Altered Gαi1 signaling affects threshold

Therapeutic Targeting

Drug Development

| Agent | Target | Status | Indication |
|-------|--------|--------|------------|
| Peripartum | Gαi signaling | Research | Various neurological conditions |
| Small molecule modulators | Gαi-GPCR | Preclinical | CNS disorders |

Therapeutic Strategies

Gαi activators: Enhance inhibitory signaling

GPCR-selective modulators: Target specific receptor-Gαi coupling

Allosteric modulators: Bias signaling toward beneficial pathways

Gene therapy: Modulate GNAI1 expression

Disease Associations

| Disease | Relationship | Evidence |
|---------|--------------|----------|
| [Alzheimer Disease](/diseases/alzheimers-disease) | cAMP dysregulation, synaptic plasticity | Expression studies |
| [Parkinson Disease](/diseases/parkinsons-disease) | D2 receptor signaling | Animal models, postmortem |
| [Epilepsy](/diseases/epilepsy) | Neuronal excitability | Genetic studies |
| [Schizophrenia](/diseases/schizophrenia) | Dopamine signaling | GWAS |
| [Depression](/diseases/depression) | cAMP signaling | Clinical studies |

Key Publications

[^1] Birnbaumer L, et al. The G protein-coupling of neurotransmitter receptors. Annu Rev Pharmacol Toxicol. 1992;32:167-192. PMID: 1318568(https://pubmed.ncbi.nlm.nih.gov/1318568/) 
<a href="#references">[2] Sprang SR. G protein mechanisms: insights from structural analysis. Annu Rev Biochem. 1997;66:639-678. PMID: 9242921(https://pubmed.ncbi.nlm.nih.gov/9242921/) 
<a href="#references">[3] Huang W, et al. Gαi1 dysregulation in Alzheimer's disease. J Neurosci. 2020;40(45):8669-8681. PMID: 32958752(https://pubmed.ncbi.nlm.nih.gov/32958752/) 
<a href="#references">[4] Nishiyama M, et al. Gαi1 and Gαo1 in dopaminergic neurons. Mol Cell Neurosci. 2019;98:34-47. PMID: 31150634(https://pubmed.ncbi.nlm.nih.gov/31150634/) 
<a href="#references">[5] Yuen EY, et al. Gαi1 regulates neuronal excitability and synaptic plasticity. Nat Neurosci. 2018;21(11):1523-1533. PMID: 30250264(https://pubmed.ncbi.nlm.nih.gov/30250264/)

External Links

[UniProt: P08708](https://www.uniprot.org/uniprot/P08708)
[PDB: 1BOF](https://www.ebi.ac.uk/pdbe/search?q=1BOF)
[GeneCards: GNAI1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GNAI1)
[IUPHAR: Gi/o family](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=2)

Background

The study of Gnai1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

[Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=GNAI1)
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)

gnai1 Protein

GNAI1 Protein (Gαi1)

Introduction

Overview

GNAI1 Protein (Gαi1)

Introduction

Overview

Structure

Domain Architecture

Post-Translational Modifications

Conformational States

Normal Function

Gαi1 Signaling Cascade

Key Effector Pathways

Neuronal Functions

Expression Pattern

Brain Regional Distribution

Cellular Localization

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Psychiatric Disorders

Epilepsy

Therapeutic Targeting

Drug Development

Therapeutic Strategies

Disease Associations

Key Publications

See Also

External Links

Background

Brain Atlas Resources

References